GTCR Is Said to Near $4.8 Billion Deal to Buy Advent’s Zentiva
Buyout firm GTCR is nearing a deal to buy generic drugmaker Zentiva in a deal that could be valued at…
Buyout firm GTCR is nearing a deal to buy generic drugmaker Zentiva in a deal that could be valued at…